Literature DB >> 11675056

Gain in bone mineral mass in prepubertal girls 3.5 years after discontinuation of calcium supplementation: a follow-up study.

J P Bonjour1, T Chevalley, P Ammann, D Slosman, R Rizzoli.   

Abstract

BACKGROUND: Calcium supplementation during childhood and adolescence increases bone-mass accrual. Whether or not this benefit persists after discontinuation of supplementation is not known. We previously showed a favourable effect of milk-extracted calcium phosphate incorporated in various foods on accumulation of bone mineral mass in 8-year-old girls. We now report the results of a follow-up study undertaken more than 3 years after the end of calcium supplementation.
METHODS: Anthropometric and bone variables were measured in 116 of the 144 girls whose data had been studied at the end of the supplementation period. The mean time elapsed between the end of the intervention period and this follow-up measurement was 3.5 years. Areal bone mineral density was measured by dual-energy X-ray absorptiometry at the same six skeletal sites as those studied during the intervention phase.
FINDINGS: We were able to remeasure 62 and 54 girls of the calcium-supplemented and placebo groups, respectively. The increase from baseline in the overall mean bone mineral density of the six skeletal sites was still highly significant (calcium-supplemented group 179 mg/cm(2) [SE 8] vs placebo group 151 mg/cm(2) [7], p=0.012). A significant difference in favour of the supplemented group was also seen with respect to mean bone mineral content (p=0.031) and mean bone area (p=0.04). Difference in pubertal maturation did not seem to account for the recorded differences.
INTERPRETATION: Our results suggest that this form of milk-extracted calcium phosphate taken during the prepubertal period can modify the trajectory of bone mass growth and cause a long-standing increase in bone mass accrual, which lasts beyond the end of supplementation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11675056     DOI: 10.1016/S0140-6736(01)06342-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  40 in total

Review 1.  Adolescence: the period of dramatic bone growth.

Authors:  Connie M Weaver
Journal:  Endocrine       Date:  2002-02       Impact factor: 3.633

Review 2.  Bone mass acquisition in healthy children.

Authors:  J H Davies; B A J Evans; J W Gregory
Journal:  Arch Dis Child       Date:  2005-04       Impact factor: 3.791

Review 3.  How has research in the last five years changed my clinical practice?

Authors:  A Bush
Journal:  Arch Dis Child       Date:  2005-08       Impact factor: 3.791

Review 4.  How does exercise affect bone development during growth?

Authors:  German Vicente-Rodríguez
Journal:  Sports Med       Date:  2006       Impact factor: 11.136

5.  Skeletal benefits from calcium supplementation are limited in children with calcium intakes near 800 mg daily.

Authors:  S Iuliano-Burns; X-F Wang; A Evans; J-P Bonjour; E Seeman
Journal:  Osteoporos Int       Date:  2006-09-22       Impact factor: 4.507

6.  Physical activity, calcium intake and childhood bone mineral: a population-based cross-sectional study.

Authors:  N C Harvey; Z A Cole; S R Crozier; M Kim; G Ntani; L Goodfellow; S M Robinson; H M Inskip; K M Godfrey; E M Dennison; N Wareham; U Ekelund; C Cooper
Journal:  Osteoporos Int       Date:  2011-05-12       Impact factor: 4.507

7.  β-Ecdysone Augments Peak Bone Mass in Mice of Both Sexes.

Authors:  Weiwei Dai; HongLiang Zhang; Zhendong A Zhong; Li Jiang; Haiyan Chen; Yu-An Evan Lay; Alexander Kot; Robert O Ritchie; Nancy E Lane; Wei Yao
Journal:  Clin Orthop Relat Res       Date:  2015-08       Impact factor: 4.176

Review 8.  Strontium ranelate: a novel mode of action leading to renewed bone quality.

Authors:  Patrick Ammann
Journal:  Osteoporos Int       Date:  2005-01       Impact factor: 4.507

9.  Polymorphisms in the low-density lipoprotein receptor-related protein 5 (LRP5) gene are associated with variation in vertebral bone mass, vertebral bone size, and stature in whites.

Authors:  Serge L Ferrari; Samuel Deutsch; Urmila Choudhury; Thierry Chevalley; Jean-Philippe Bonjour; Emmanouil T Dermitzakis; Rene Rizzoli; Stylianos E Antonarakis
Journal:  Am J Hum Genet       Date:  2004-04-07       Impact factor: 11.025

10.  Inhibition of the progesterone nuclear receptor during the bone linear growth phase increases peak bone mass in female mice.

Authors:  Wei Yao; Weiwei Dai; Mohammad Shahnazari; Aaron Pham; Zhiqiang Chen; Haiyan Chen; Min Guan; Nancy E Lane
Journal:  PLoS One       Date:  2010-07-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.